The 2016 revision of the World Health Organization classification of lymphoid neoplasms

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933 · see citing works

WHO classification of haematolymphoid tumours

Gaillard, F., & Gerstenmaier, J. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,763 · see citing works

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S. A., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,007 · see citing works

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,512 · see citing works

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P. S., Manning, R. J., Patterson, C. J., Tripsas, C. K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,288 · see citing works

SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C. L., Stevenson, K. E., Werner, L. L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,081 · see citing works

BRAF MUTATIONS IN HAIRY CELL LEUKEMIA

Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014209 · Cited by 1,073 · see citing works

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Hummel, M., Bentink, S., Berger, H., Klapper, W., Weßendorf, S., Barth, T. F. E., Bernd, H., Cogliatti, S., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,002 · see citing works

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez‐Trillos, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 987 · see citing works

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Johnson, N. A., Slack, G. W., Savage, K. J. J., Connors, J. M., Ben‐Neriah, S., Rogić, S., Scott, D. W., Tan, K. L., Steidl, C., Sehn, L. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0985 · Cited by 975 · see citing works

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S. G., Xiao, W., Zhang, M., Wright, G. W., Shaffer, A. L., Hodson, D. J., Buras, E. D., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 920 · see citing works

Molecular Diagnosis of Burkitt's Lymphoma

Davé, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P. M., Boerma, E.-J. G., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897 · see citing works

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Beà, S., Valdés‐Mas, R., Villamor, N., Gutiérrez‐Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2015) · Nature · doi:10.1038/nature14666 · Cited by 813 · see citing works

Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia

Rajala, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H. A., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T. L., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 775 · see citing works

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

Okosun, J., Bödör, C., Wang, J., Araf, S., Yang, C.-Y., Pan, C., Boller, S., Cittaro, D., Bożek, M., Iqbal, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2856 · Cited by 731 · see citing works

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

Sakata‐Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Tsuyama, N., Sato‐Otsubo, A., Okuno, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2872 · Cited by 649 · see citing works

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Scott, D. W., Wright, G. W., Williams, P. M., Lih, C., Walsh, W. D., Jaffe, E. S., Rosenwald, A., Campo, E., Chan, W. C., Connors, J. M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536433 · Cited by 627 · see citing works

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas

Palomero, T., Couronné, L., Khiabanian, H., Kim, M., Ambesi‐Impiombato, A., Pérez-García, A., Carpenter, Z., Abate, F., Allegretta, M., Haydu, J. E., et al. (2014) · Nature Genetics · doi:10.1038/ng.2873 · Cited by 623 · see citing works

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Pastore, A., Jurinović, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., Pott, C., Kopp, N., Murakami, M. A., Horn, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00169-2 · Cited by 619 · see citing works

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

Fabbri, G., Rasi, S., Rossi, D., Trifonov, V. A., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S. M., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110921 · Cited by 606 · see citing works

The genetic landscape of mutations in Burkitt lymphoma

Love, C., Sun, Z., Jima, D. D., Li, G., Zhang, J., Miles, R. R., Richards, K. L., Dunphy, C. H., Choi, W. W. L., Srivastava, G., et al. (2012) · Nature Genetics · doi:10.1038/ng.2468 · Cited by 598 · see citing works

EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression

Dojcinov, S. D., Venkataraman, G., Raffeld, M. A., et al. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf8622 · Cited by 572 · see citing works

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Iqbal, J., Wright, G. W., Wang, C., Rosenwald, A., Gascoyne, R. D., Weisenburger, D. D., Greiner, T. C., Smith, L. M., Guo, S., Wilcox, R. A., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536359 · Cited by 552 · see citing works

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Beà, S., Valdés‐Mas, R., Villamor, N., Gutiérrez‐Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2016) · Nature · doi:10.1038/nature18910 · Cited by 546 · see citing works

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

Beà, S., Valdés‐Mas, R., Navarro, A., Salaverría, I., Martin‐García, D., Jares, P., Giné, E., Pinyol, M., Royo, C., Nadeu, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314608110 · Cited by 513 · see citing works

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

Cairns, R. A., Iqbal, J., Lemonnier, F., Küçük, C., de Leval, L., Jaïs, J., Parrens, M., Martin, A., Xerri, L., Brousset, P., et al. (2012) · Blood · doi:10.1182/blood-2011-11-391748 · Cited by 505 · see citing works

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

Lemonnier, F., Couronné, L., Parrens, M., Jaïs, J., Travert, M., Lamant, L., Tournillac, O., Rousset, T., Fabiani, B., Cairns, R. A., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408542 · Cited by 499 · see citing works

ANAPLASTIC T-CELL LYMPHOMA IN PROXIMITY TO A SALINE-FILLED BREAST IMPLANT

Keech, J. A., & Creech, B. J. (1997) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199708000-00065 · Cited by 473 · see citing works

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Castellar, E. R. P., Jaffe, E. S., SAID, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571091 · Cited by 471 · see citing works

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

Rossi, D., Rasi, S., Spina, V., Bruscaggin, A., Monti, S. M., Ciardullo, C., Deambrogi, C., Khiabanian, H., Serra, R., Bertoni, F., et al. (2012) · Blood · doi:10.1182/blood-2012-09-458265 · Cited by 467 · see citing works

EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

Kimura, H., Ito, Y., Kawabe, S., et al. (2011) · Blood · doi:10.1182/blood-2011-10-381921 · Cited by 449 · see citing works

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Crescenzo, R., Abate, F., Lasorsa, E., Tabbò, F., Gaudiano, M., Chiesa, N., Giacomo, F. D., Spaccarotella, E., Barbarossa, L., Ercole, E., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.006 · Cited by 445 · see citing works

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

the ICGC MMML-Seq Project (2012) · Nature Genetics · doi:10.1038/ng.2469 · Cited by 435 · see citing works

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Jerez, A., Clemente, M. J., Makishima, H., et al. (2012) · Blood · doi:10.1182/blood-2012-06-435297 · Cited by 425 · see citing works

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Clemens, M. W., Medeiros, L. J., Butler, C. E., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3412 · Cited by 422 · see citing works

Diffuse large B-cell lymphoma—treatment approaches in the molecular era

Roschewski, M. J., Staudt, L. M., & Wilson, W. H. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.197 · Cited by 413 · see citing works

Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients

Miranda, R. N., Aladily, T. N., Prince, H. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.7911 · Cited by 406 · see citing works

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

Scott, D. W., Mottok, A., Ennishi, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2383 · Cited by 406 · see citing works

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N. A., Alkan, C., Williams, J. C., Avery, K. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7025 · Cited by 394 · see citing works

Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenström macroglobulinemia

Treon, S. P., Cao, Y., Xu, L., et al. (2014) · Blood · doi:10.1182/blood-2014-01-550905 · Cited by 388 · see citing works

Molecular pathogenesis of mantle cell lymphoma

Jares, P., Colomer, D., & Campo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61272 · Cited by 384 · see citing works

B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia

Landgren, O., Albitar, M. X., Ma, W., Abbasi, F., Hayes, R. B., Ghia, P., Marti, G. E., & Caporaso, N. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806122 · Cited by 366 · see citing works

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

Green, M. R., Kihira, S., Liu, C. L., Nair, R. V., Salari, R., Gentles, A. J., Irish, J. M., Stehr, H., Vicente‐Dueñas, C., Romero-Camarero, I., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501199112 · Cited by 358 · see citing works

Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Immunohistologic and Clinical Correlation

Fan, Z., Natkunam, Y., Bair, E., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00007 · Cited by 347 · see citing works

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Kridel, R., Meissner, B., Rogić, S., Boyle, M., Telenius, A., Woolcock, B. W., Gunawardana, J., Jenkins, C. R., Cochrane, C., Ben‐Neriah, S., et al. (2011) · Blood · doi:10.1182/blood-2011-11-391474 · Cited by 335 · see citing works

Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone

Feldman, A. L., Arber, D. A., Pittaluga, S., Martı́nez, A., Burke, J. S., Raffeld, M. A., Camós, M., Warnke, R. A., & Jaffe, E. S. (2008) · Blood · doi:10.1182/blood-2007-11-124792 · Cited by 333 · see citing works

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Bödör, C., Großmann, V., Popov, N., Okosun, J., Ó’Riain, C., Tan, K. L., Marzec, J., Araf, S., Wang, J., Lee, A. M., et al. (2013) · Blood · doi:10.1182/blood-2013-04-496893 · Cited by 325 · see citing works

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

Dojcinov, S. D., Venkataraman, G., Pittaluga, S., Włodarska, I., Schrager, J. A., Raffeld, M. A., Hills, R. K., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2010-12-323238 · Cited by 312 · see citing works

Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma

Toro, J. R., Liewehr, D. J., Pabby, N., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1597 · Cited by 304 · see citing works

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

Sander, S., Calado, D. P., Srinivasan, L., Köchert, K., Zhang, B., Rosołowski, M., Rodig, S. J., Holzmann, K., Stilgenbauer, S., Siebert, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.012 · Cited by 300 · see citing works

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

Feldman, A. L., Doǧan, A., Smith, D. I., Law, M. E., Ansell, S. M., Johnson, S. H., Porcher, J. C., Özsan, N., Wieben, E. D., Eckloff, B. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-303305 · Cited by 296 · see citing works

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

Rajala, H. L. M., Eldfors, S., Kuusanmäki, H. A., van Adrichem, A. J., Olson, T. L., Lagström, S., Andersson, E. I., Jerez, A., Clemente, M. J., Yan, Y., et al. (2013) · Blood · doi:10.1182/blood-2012-12-474577 · Cited by 294 · see citing works

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Salaverría, I., Philipp, C., Oschlies, I., Kohler, C. W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330795 · Cited by 289 · see citing works

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas, P., Hadzidimitriou, A., Sutton, L.-A., Rossi, D., Minga, E., Villamor, N., Larráyoz, M., Kmínková, J., Agathangelidis, A., Davis, Z. A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.196 · Cited by 287 · see citing works

Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008

Cohen, J. I., Kimura, H., Nakamura, S., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp064 · Cited by 283 · see citing works

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

Nicolae, A., Pittaluga, S., Abdullah, S. A. A., Steinberg, S. M., Pham, T., DAVIES-HILL, T. M., Xi, L., Raffeld, M. A., & Jaffe, E. S. (2015) · Blood · doi:10.1182/blood-2015-02-630632 · Cited by 279 · see citing works

High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias

Waterfall, J. J., Arons, E., Walker, R. L., Pineda, M. A., Roth, L., Killian, J. K., Abaan, O. D., Davis, S. R., Kreitman, R. J., & Meltzer, P. S. (2013) · Nature Genetics · doi:10.1038/ng.2828 · Cited by 274 · see citing works

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Kiel, M. J., Velusamy, T., Rolland, D. C. M., Sahasrabuddhe, A. A., Chung, F., Bailey, N. G., Schrader, A., Li, B., Li, J. Z., Ozel, A. B., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559542 · Cited by 256 · see citing works

Whole-Genome Analysis and HLA Genotyping of Enteropathy-Type T-Cell Lymphoma Reveals 2 Distinct Lymphoma Subtypes

deLeeuw, R. J., Zettl, A., Klinker, E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.036 · Cited by 252 · see citing works

Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers

Rodríguez-Pinilla, S. M., Roncador, G., Rodríguez‐­Peralto, J. L., Mollejo, M., García, J. F., Montes‐Moreno, S., Camacho, F. I., Ortiz-Romero, P. L., Limeres-González, M. Á., Torres, A., et al. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31818e52fe · Cited by 247 · see citing works

Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD

Ohshima, K., Kimura, H., Yoshino, T., et al. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02213.x · Cited by 247 · see citing works

Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases

Schmatz, A.-I., Streubel, B., Kretschmer‐Chott, E., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.9193 · Cited by 232 · see citing works

Frequent detection of BRAFV 600E mutations in histiocytic and dendritic cell neoplasms

Go, H., Jeon, Y. K., Huh, J., et al. (2014) · Histopathology · doi:10.1111/his.12416 · Cited by 229 · see citing works

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients

Jeromin, S., Weißmann, S., Haferlach, C., et al. (2013) · Leukemia · doi:10.1038/leu.2013.263 · Cited by 229 · see citing works

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Salaverría, I., Martín‐Guerrero, I., Wagener, R., et al. (2014) · Blood · doi:10.1182/blood-2013-06-507996 · Cited by 229 · see citing works

A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases

Saggini, A., Gulia, A., Argényi, Z. B., et al. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e75356 · Cited by 224 · see citing works

B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma

Young, R. M., Shaffer, A. L., Phelan, J. D., & Staudt, L. M. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.008 · Cited by 223 · see citing works

Primary Cutaneous CD4+ Small-/Medium-Sized Pleomorphic T-Cell Lymphoma: A Cutaneous Nodular Proliferation of Pleomorphic T Lymphocytes of Undetermined Significance? A Study of 136 Cases

Beltraminelli, H., Leinweber, B., Kerl, H., et al. (2009) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31819f19bb · Cited by 220 · see citing works

Hepatosplenic ɑß T-Cell Lymphomas

Macon, W. R., Levy, N. B., Kurtin, P. J., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200103000-00002 · Cited by 219 · see citing works

Increased frequency (12%) of circulating chronic lymphocytic leukemia–like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach

Nieto, W. G., Almeida, J., Romero, A. E., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197368 · Cited by 216 · see citing works

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes

Laurent, C., Delas, A., Gaulard, P., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv575 · Cited by 215 · see citing works

CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma

Salaverría, I., Royo, C., Carvajal-Cuenca, A., et al. (2012) · Blood · doi:10.1182/blood-2012-08-452284 · Cited by 209 · see citing works

C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma

Roccaro, A. M., Sacco, A., Jiménez, C., Maiso, P., Moschetta, M., Mishima, Y., Aljawai, Y. M., Şahin, İ., Kuhné, M. R., Cardarelli, P. M., et al. (2014) · Blood · doi:10.1182/blood-2014-03-564583 · Cited by 207 · see citing works

Angioinvasive Lymphomatoid Papulosis

Kempf, W., Kazakov, D. V., Schärer, L., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182648596 · Cited by 206 · see citing works

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract

Perry, A. M., Warnke, R. A., Hu, Q., et al. (2013) · Blood · doi:10.1182/blood-2013-07-512830 · Cited by 199 · see citing works

Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases

Shao, H., Xi, L., Raffeld, M. A., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.102 · Cited by 198 · see citing works

Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis

Karai, L. J., Kadin, M. E., Hsi, E. D., Sluzevich, J. C., Ketterling, R. P., Knudson, R. A., & Feldman, A. L. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318282d01e · Cited by 198 · see citing works

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

Giné, E., Martı́nez, A., Villamor, N., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.022277 · Cited by 196 · see citing works

Type II Enteropathy-Associated T-Cell Lymphoma

Chan, J. K. C., Chan, A. C. L., Cheuk, W., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318222dfcd · Cited by 195 · see citing works

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Hartmann, S., Eichenauer, D. A., Plütschow, A., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515825 · Cited by 193 · see citing works

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

Villamor, N., Conde, L., Martínez‐Trillos, A., Cazorla, M., Navarro, A., Beà, S., López, C., Colomer, D., Pinyol, M., Aymerich, M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.357 · Cited by 188 · see citing works

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Wang, T., Feldman, A. L., Wada, D. A., Lu, Y., Polk, A., Briski, R. E., Ristow, K. M., Habermann, T. M., Thomas, D. G., Ziesmer, S. C., et al. (2014) · Blood · doi:10.1182/blood-2013-12-544809 · Cited by 187 · see citing works

Indolent CD8-positive Lymphoid Proliferation of the Ear

Petrella, T., Maubec, E., Cornillet‐Lefèbvre, P., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318068b527 · Cited by 182 · see citing works

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

Pasqualucci, L., & Dalla‐Favera, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.005 · Cited by 180 · see citing works

Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome

García‐Herrera, A., Colomo, L., Camós, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1307 · Cited by 174 · see citing works

Cutaneous γδ T-cell Lymphomas

Guitart, J., Weisenburger, D. D., Subtil, A., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826a5038 · Cited by 173 · see citing works

Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma

Quintanilla‐Martínez, L., Ridaura, C., Nagl, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-502203 · Cited by 172 · see citing works

Follicular Lymphomas in Children and Young Adults

Liu, Q., Salaverría, I., Pittaluga, S., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826b9b57 · Cited by 167 · see citing works

Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior

Grogg, K. L., Jung, S., Erickson, L. A., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.40 · Cited by 166 · see citing works

Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma

Jegalian, A. G., Eberle, F. C., Pack, S., et al. (2011) · Blood · doi:10.1182/blood-2011-05-355255 · Cited by 163 · see citing works

Peripheral T‐cell and NK ‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVI th meeting of the European Association for Haematopathology and the Society for Hematopathology

Attygalle, A. D., Cabeçadas, J., Gaulard, P., et al. (2013) · Histopathology · doi:10.1111/his.12251 · Cited by 162 · see citing works

In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior

Carvajal-Cuenca, A., Sua, L. F., Silva, N. M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.052621 · Cited by 162 · see citing works

EBV-positive Mucocutaneous Ulcer in Organ Transplant Recipients

Hart, M., Thakral, B., Yohe, S. L., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000282 · Cited by 162 · see citing works

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement

Louissaint, A., Ackerman, A. M., Dias-Santagata, D. C., et al. (2012) · Blood · doi:10.1182/blood-2012-05-429514 · Cited by 159 · see citing works

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma

Boudová, L., Torlakovic, E., Delabie, J., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0626 · Cited by 157 · see citing works

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Katzenberger, T., Kalla, J., Leich, E., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168682 · Cited by 155 · see citing works

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

Queirós, A. C., Villamor, N., Clot, G., Martínez‐Trillos, A., Kulis, M., Navarro, A., Penas, E. M. M., Jayne, S., Majid, A., Richter, J., et al. (2014) · Leukemia · doi:10.1038/leu.2014.252 · Cited by 155 · see citing works

CD10−MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features

Karube, K., Guo, Y., Suzumiya, J., et al. (2006) · Blood · doi:10.1182/blood-2006-09-045989 · Cited by 153 · see citing works

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

Swerdlow, S. H. (2014) · Hematology · doi:10.1182/asheducation-2014.1.90 · Cited by 147 · see citing works

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

Falchi, L., Keating, M. J., Marom, E. M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536169 · Cited by 146 · see citing works

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

Roulland, S., Kelly, R. S., Morgado, E., Sungalee, S., Solal‐Céligny, P., Colombat, P., Jouve, N., Palli, D., Pala, V. M., Tumino, R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.8190 · Cited by 139 · see citing works

Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study

Piccaluga, P. P., Fuligni, F., Leo, A. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.5611 · Cited by 136 · see citing works

T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders

Swerdlow, S. H. (2007) · American Journal of Clinical Pathology · doi:10.1309/lyxn3rgf7d7kpyg0 · Cited by 134 · see citing works

TCR-γ Expression in Primary Cutaneous T-cell Lymphomas

Rodríguez-Pinilla, S. M., Ortiz-Romero, P. L., Monsálvez, V., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318275d1a2 · Cited by 132 · see citing works

Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas

Nicolae, A., Xi, L., Pittaluga, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.200 · Cited by 130 · see citing works

Peripheral T-cell Lymphomas of Follicular T-Helper Cell Derivation With Hodgkin/Reed-Sternberg Cells of B-cell Lineage

Nicolae, A., Pittaluga, S., Venkataraman, G., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182785610 · Cited by 129 · see citing works

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements

King, R. L., Dao, L. N., McPhail, E. D., Jaffe, E. S., SAID, J. W., Swerdlow, S. H., Sattler, C. A., Ketterling, R. P., Sidhu, J. S., Hsi, E. D., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000500 · Cited by 122 · see citing works

The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing

Swerdlow, S. H., Kuzu, I., Doǧan, A., et al. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1858-9 · Cited by 120 · see citing works

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?

Hartmann, S., Döring, C., Jakobus, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078812 · Cited by 114 · see citing works

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Agnelli, L., Mereu, E., Pellegrino, E., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405555 · Cited by 108 · see citing works

Early lesions of follicular lymphoma: a genetic perspective

Mamessier, É., Song, J. Y., Eberle, F. C., Pack, S., Drevet, C., Chetaille, B., Abdullaev, Z., Adélaı̈de, J., Birnbaum, D., Chaffanet, M., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.094474 · Cited by 108 · see citing works

MYC Alterations in Diffuse Large B-Cell Lymphomas

Karube, K., & Campo, E. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.009 · Cited by 105 · see citing works

Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)

Rawstron, A. C., Shanafelt, T. D., Lanasa, M. C., et al. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20533 · Cited by 103 · see citing works

MYD 88 L265P and CXCR 4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity

Schmidt, J., Federmann, B., Schindler, N. M., Steinhilber, J., Bonzheim, I., Fend, F., & Quintanilla‐Martínez, L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13361 · Cited by 100 · see citing works

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers

Nam‐Cha, S. H., Montes‐Moreno, S., Salcedo, M. T., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.54 · Cited by 99 · see citing works

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

Ferreiro, J. L., Morscio, J., Dierickx, D., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.124305 · Cited by 97 · see citing works

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

Vardi, A., Dagklis, A., Scarfò, L., et al. (2013) · Blood · doi:10.1182/blood-2012-12-471698 · Cited by 96 · see citing works

Cytotoxic T-cell and NK-cell Lymphomas

Swerdlow, S. H., Jaffe, E. S., Brousset, P., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000295 · Cited by 94 · see citing works

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

Gibson, S. E., Swerdlow, S. H., Ferry, J. A., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.042333 · Cited by 93 · see citing works

Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease

Haroche, J., & Abla, O. (2015) · Hematology · doi:10.1182/asheducation-2015.1.571 · Cited by 93 · see citing works

Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas

Balagué, O., Martı́nez, A., Colomo, L., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3180339f18 · Cited by 91 · see citing works

Recurrent mutation of JAK3 in T‐cell prolymphocytic leukemia

Bergmann, A. K., Schneppenheim, S., Seifert, M., Betts, M. J., Haake, A., López, C., Penas, E. M. M., Vater, I., Jayne, S., Dyer, M. J. S., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22141 · Cited by 90 · see citing works

Precision therapy for lymphoma—current state and future directions

Intlekofer, A. M., & Younes, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.137 · Cited by 88 · see citing works

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Xochelli, A., Kalpadakis, C. H., Gardiner, A. C., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515155 · Cited by 88 · see citing works

Young Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma Benefit From Intensified Chemotherapy With ACVBP Plus Rituximab Compared With CHOP Plus Rituximab: Analysis of Data From the Groupe d'Etudes des Lymphomes de l'Adulte/Lymphoma Study Association Phase III Trial LNH 03-2B

Molina, T. J., Canioni, D., Copie‐Bergman, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.9493 · Cited by 88 · see citing works

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity

Thompson, P. A., Lade, S., Webster, H. R., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.026237 · Cited by 87 · see citing works

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

Xing, K. H., Connors, J. M., Lai, A., et al. (2014) · Blood · doi:10.1182/blood-2013-12-541078 · Cited by 86 · see citing works

Dendritic Cell and Histiocytic Neoplasms: Biology, Diagnosis, and Treatment

Dalia, S. M., Shao, H., Sagatys, E. M., et al. (2014) · Cancer Control · doi:10.1177/107327481402100405 · Cited by 86 · see citing works

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

Moroch, J., Copie‐Bergman, C., de Leval, L., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318268d9ff · Cited by 85 · see citing works

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma

Hamadeh, F., MacNamara, S., Aguilera, N. S. I., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.120 · Cited by 81 · see citing works

Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma

Hartmann, S., Döring, C., Vucic, E. A., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13310 · Cited by 76 · see citing works

T-cell Receptor (TCR) Phenotype of Nodal Epstein-Barr Virus (EBV)-positive Cytotoxic T-cell Lymphoma (CTL)

Kato, S. X., Asano, N., Miyata‐Takata, T., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000323 · Cited by 73 · see citing works

Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas

Martín‐Guerrero, I., Salaverría, I., Burkhardt, B., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.073916 · Cited by 73 · see citing works

Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan

Tomita, S., Kikuti, Y. Y., Carreras, J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.85 · Cited by 70 · see citing works

Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features

Morabito, F., Mosca, L., Cutrona, G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0622 · Cited by 69 · see citing works

Clinicopathologic Characteristics and Outcomes of Histiocytic and Dendritic Cell Neoplasms: The Moffitt Cancer Center Experience Over the Last Twenty Five Years

Dalia, S. M., Jaglal, M. V., Chervenick, P. A., et al. (2014) · Cancers · doi:10.3390/cancers6042275 · Cited by 69 · see citing works

Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays

Ciccone, M., Agostinelli, C., Rigolin, G. M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.247 · Cited by 68 · see citing works

Langerhans cell sarcoma arising from chronic lymphocytic lymphoma/small lymphocytic leukemia: lineage analysis and braf v600e mutation study

Cai, D., Chen, W., Jaffe, R., et al. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.114172 · Cited by 67 · see citing works

Genomic and epigenomic co-evolution in follicular lymphomas

Loeffler, M., Kreuz, M., Haake, A., Hasenclever, D., Trautmann, H., Arnold, C., Winter, K., Koch, K., Klapper, W., Scholtysik, R., et al. (2014) · Leukemia · doi:10.1038/leu.2014.209 · Cited by 66 · see citing works

Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics

Takata, K., Sato, Y., Nakamura, N., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.127 · Cited by 64 · see citing works

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma

Tan, S. Y., As, O., Mk, A., et al. (2011) · Leukemia · doi:10.1038/leu.2010.295 · Cited by 63 · see citing works

Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

Pillai, R. K., Surti, U., & Swerdlow, S. H. (2013) · Haematologica · doi:10.3324/haematol.2013.085506 · Cited by 63 · see citing works

Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens

Masqué‐Soler, N., Szczepanowski, M., Kohler, C. W., et al. (2013) · Blood · doi:10.1182/blood-2013-06-508937 · Cited by 62 · see citing works

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

Schmidt, J., Salaverría, I., Haake, A., Bonzheim, I., Adam, P., Montes‐Moreno, S., Piris, M. A., Fend, F., Siebert, R., & Quintanilla‐Martínez, L. (2013) · Leukemia · doi:10.1038/leu.2013.307 · Cited by 62 · see citing works

Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity

Ratei, R., Hummel, M., Anagnostopoulos, I., Jähne, D., Arnold, R., Dörken, B., Mathas, S., Benter, T., Dudeck, O., Ludwig, W.-D., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.021212 · Cited by 62 · see citing works

Accurate Classification of Germinal Center B-Cell–Like/Activated B-Cell–Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase–Multiplex Ligation-Dependent Probe Amplification Assay

Mareschal, S., Ruminy, P., Bagacean, C., et al. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.01.007 · Cited by 60 · see citing works

Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?

Tellier, J., Menard, C., Roulland, S., Martin, N., Monvoisin, C., Chasson, L., Nadel, B., Gaulard, P., Schiff, C., & Tarte, K. (2014) · Blood · doi:10.1182/blood-2013-12-545954 · Cited by 51 · see citing works

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Cyclin D1 Positive Proliferation Centers Do Not HaveCCND1Translocations or Gains and Lack SOX11 Expression

Gradowski, J. F., Sargent, R. L., Craig, F. E., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpivkzrmpf93et · Cited by 48 · see citing works

The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum

Momose, S., Weißbach, S., Pischimarov, J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.34 · Cited by 47 · see citing works

Indolent course of cutaneous gamma‐delta T‐cell lymphoma

Endly, D. C., Weenig, R. H., Peters, M. S., et al. (2013) · Journal of Cutaneous Pathology · doi:10.1111/cup.12091 · Cited by 45 · see citing works

MYC in DLBCL: partners matter

Campo, E. (2015) · Blood · doi:10.1182/blood-2015-10-671362 · Cited by 35 · see citing works

Molecular lesions of signalling pathway genes in clonal B‐cell lymphocytosis with marginal zone features

Bruscaggin, A., Monti, S. M., Arcaini, L., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13052 · Cited by 30 · see citing works

ID3 mutations are recurrent events in double-hit B-cell lymphomas.

Gebauer, N., Bernard, V., Feller, A. C., et al. (2013) · PubMed · Cited by 25 · see citing works

Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene

Gibson, S. E., Leeman‐Neill, R. J., Jain, S., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13844 · Cited by 25 · see citing works

A Mechanism-Driven Treatment for Chronic Lymphocytic Leukemia?

Foà, R., & Guarini, A. R. (2013) · New England Journal of Medicine · doi:10.1056/nejme1303054 · Cited by 21 · see citing works

High-Grade B-Cell Lymphoma

Wang, X., & Huang, Q. (2020) · Springer eBooks · doi:10.1007/978-3-030-32189-5_7 · Cited by 20 · see citing works

The expanding spectrum of EBV+ lymphomas

SAID, J. W. (2015) · Blood · doi:10.1182/blood-2015-06-648097 · Cited by 19 · see citing works

Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma

Hamadeh, F., MacNamara, S., Bacon, C. M., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.108688 · Cited by 12 · see citing works

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Arber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood · doi:10.1182/blood.2022015850 · Cited by 2,945 · see citing works

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31366-0 · Cited by 2,430 · see citing works

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Locke, F. L., Miklos, D. B., Jacobson, C. A., Perales, M.-A., Kersten, M.-J., Oluwole, O. O., Ghobadi, A., Rapoport, A. P., McGuirk, J., Pagel, J. M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116133 · Cited by 1,607 · see citing works

EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies

Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216114 · Cited by 732 · see citing works

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Thieblemont, C., Phillips, T., Ghesquieres, H., Cheah, C. Y., Clausen, M. R., Cunningham, D., Do, Y. R., Feldman, T., Gasiorowski, R., Jurczak, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01725 · Cited by 584 · see citing works

The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship

Duggan, M. A., Anderson, W. F., Altekruse, S., Penberthy, L., & Sherman, M. E. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000749 · Cited by 472 · see citing works

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

Hutchings, M., Mous, R., Clausen, M. R., Johnson, P., Linton, K. M., Chamuleau, M. E. D., Lewis, D. J., Sureda Balari, A., Cunningham, D., Oliveri, R. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00889-8 · Cited by 337 · see citing works

Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults

Bosch de Basea, M., Thierry-Chef, I., Harbron, R., Hauptmann, M., Byrnes, G., Bernier, M.-O., Le Cornet, L., Dabin, J., Ferro, G., Istad, T. S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02620-0 · Cited by 349 · see citing works

Global patterns and trends in the incidence of non-Hodgkin lymphoma

Miranda-Filho, A., Piñeros, M., Znaor, A., Marcos-Gragera, R., Steliarova-Foucher, E., & Bray, F. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01155-5 · Cited by 158 · see citing works

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

Carpio, C., Bouabdallah, R., Ysebaert, L., Sancho, J.-M., Salles, G., Cordoba, R., Pinto, A., Gharibo, M., Rasco, D., Panizo, C., et al. (2020) · Blood · doi:10.1182/blood.2019002395 · Cited by 72 · see citing works

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Pria, A. D., Pinato, D., Roe, J., Naresh, K., Nelson, M., & Bower, M. (2017) · Blood · doi:10.1182/blood-2016-10-747477 · Cited by 71 · see citing works

Deep Morphology Learning Enhances <i>Ex Vivo</i> Drug Profiling-Based Precision Medicine

Heinemann, T., Kornauth, C., Severin, Y., Vladimer, G. I., Pemovska, T., Hadzijusufovic, E., Agis, H., Krauth, M.-T., Sperr, W. R., Valent, P., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0219 · Cited by 28 · see citing works

Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma

Yan, X., Zhou, Y., Huang, S., Li, X., Yu, M., Huang, J., Wang, J., Ma, Z., Jin, J., Pan, J., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2570-8 · Cited by 12 · see citing works

Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma

Falchi, L., Sureda, A., Leppä, S., Vermaat, J. S. P., Nijland, M., Christensen, J. H., de Vos, S., Holte, H., Merryman, R. W., Lugtenburg, P. J., et al. (2025) · Blood · doi:10.1182/blood.2025029909 · Cited by 15 · see citing works

Perceptions of clinical care and research among African-American patients with lymphoma

Dance, K. V., Imbody, C. B., Chen, L., McNeill, L., Payne, J. B., & Flowers, C. R. (2021) · Leukemia &amp; Lymphoma · doi:10.1080/10428194.2021.1892092 · Cited by 7 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322

Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria

Dib, A., Puig, L. B., Salvadori, D., et al. (1988) · Arquivos Brasileiros de Cardiologia